198 related articles for article (PubMed ID: 23665142)
1. New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.
Abdel-Aziz M; Abuo-Rahma Gel-D; Beshr EA; Ali TF
Bioorg Med Chem; 2013 Jul; 21(13):3839-49. PubMed ID: 23665142
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activities.
Abuo-Rahma Gel-D; Abdel-Aziz M; Beshr EA; Ali TF
Eur J Med Chem; 2014 Jan; 71():185-98. PubMed ID: 24308998
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anti-inflammatory activity and ulcerogenic liability of novel nitric oxide donating/chalcone hybrids.
Abuo-Rahma Gel-D; Abdel-Aziz M; Mourad MA; Farag HH
Bioorg Med Chem; 2012 Jan; 20(1):195-206. PubMed ID: 22137931
[TBL] [Abstract][Full Text] [Related]
4. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EA; Kaoud TS; Ahmed AF
Bioorg Chem; 2016 Dec; 69():48-63. PubMed ID: 27669120
[TBL] [Abstract][Full Text] [Related]
6. New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.
Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EAM; Kaoud T; Ahmed AFF
Bioorg Chem; 2017 Oct; 74():15-29. PubMed ID: 28738249
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-inflammatory activity of celecoxib like compounds.
Ovais S; Yaseen S; Bashir R; Rathore P; Samim M; Singh S; Nair V; Javed K
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1105-12. PubMed ID: 22957719
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives.
Shoman ME; Abdel-Aziz M; Aly OM; Farag HH; Morsy MA
Eur J Med Chem; 2009 Jul; 44(7):3068-76. PubMed ID: 18722034
[TBL] [Abstract][Full Text] [Related]
9. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
10. NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
Kashfi K; Chattopadhyay M; Kodela R
Redox Biol; 2015 Dec; 6():287-296. PubMed ID: 26298203
[TBL] [Abstract][Full Text] [Related]
11. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE
J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945
[TBL] [Abstract][Full Text] [Related]
12. 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity.
Abdel-Aziz M; Beshr EA; Abdel-Rahman IM; Ozadali K; Tan OU; Aly OM
Eur J Med Chem; 2014 Apr; 77():155-65. PubMed ID: 24631895
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids.
Abdelall EKA; Abdelhamid AO; Azouz AA
Bioorg Med Chem Lett; 2017 Sep; 27(18):4358-4369. PubMed ID: 28844389
[TBL] [Abstract][Full Text] [Related]
14. Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
Chioua M; Sucunza D; Soriano E; Hadjipavlou-Litina D; Alcázar A; Ayuso I; Oset-Gasque MJ; González MP; Monjas L; Rodríguez-Franco MI; Marco-Contelles J; Samadi A
J Med Chem; 2012 Jan; 55(1):153-68. PubMed ID: 22126405
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anticancer activity of nitric oxide donating/chalcone hybrids.
Mourad MA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
Eur J Med Chem; 2012 Aug; 54():907-13. PubMed ID: 22703846
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.
Bhandari SV; Dangre SC; Bothara KG; Patil AA; Sarkate AP; Lokwani DK; Gore ST; Deshmane BJ; Raparti VT; Khachane CV
Eur J Med Chem; 2009 Nov; 44(11):4622-36. PubMed ID: 19647903
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids.
Aziz HA; Moustafa GAI; Abuo-Rahma GEA; Rabea SM; Hauk G; Krishna VS; Sriram D; Berger JM; Abbas SH
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000180. PubMed ID: 32959443
[TBL] [Abstract][Full Text] [Related]
18. Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
Mohassab AM; Hassan HA; Abdelhamid D; Abdel-Aziz M; Dalby KN; Kaoud TS
Bioorg Chem; 2017 Dec; 75():242-259. PubMed ID: 29032325
[TBL] [Abstract][Full Text] [Related]
19. 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties.
Kumar H; Javed SA; Khan SA; Amir M
Eur J Med Chem; 2008 Dec; 43(12):2688-98. PubMed ID: 18395299
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the study of nitric oxide-donating drugs].
Zhang YH; Peng SX
Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
